Fornier, M N <br/><br/>
A phase I study of dasatinib and weekly paclitaxel for metastatic breast cancer.  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  Dec 2011 
 - 2575-2581 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1569-8041 
<br/><br/><label>Standard No.: </label>10.1093/annonc/mdr018  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Breast Neoplasms--drug therapy<br/>Breast Neoplasms, Male--drug therapy<br/>Dasatinib<br/>Edema--chemically induced<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Neoplasm Metastasis<br/>Paclitaxel--administration & dosage<br/>Pleural Effusion, Malignant--chemically induced<br/>Pyrimidines--administration & dosage<br/>Thiazoles--administration & dosage<br/>Treatment Outcome